{
    "code": "52026953",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026953",
    "time": "2021-08-13 04:41:43",
    "許可證字號": "衛部藥輸字第026953號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/12\/07",
    "發證日期": "105\/12\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202695307",
    "中文品名": "歐欣尼膜衣錠25毫克\/15毫克",
    "英文品名": "Oseni Tablets 25mg\/15 mg",
    "適應症": "Oseni (alogliptin\/pioglitazone)可用於以下狀況之成年第二型糖尿病治療: \r\n(1) 使用alogliptin 單方每日25 mg 或pioglitazone 單方每日30 mg 治療仍控制血糖不佳者。 (2) 與metformin 併用，本品適用於已使用alogliptin每日25 mg 加上metformin　(使用劑量≥每日1500 mg或已達最高耐受劑量)治 療仍控制血糖不佳者、或已使用pioglitazone 每日15或30mg 加上metfonnin(使用劑量≥全每日1500 mg 或已達最高耐受劑量) 治療仍控制血糖不佳者。 (3) 已使用alogliptin 以及pioglitazone 控制良好的患者，可與本藥品互換使用。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠PVC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/12\/07",
    "主成分略述": "PIOGLITAZONE HYDROCHLORIDE, Alogliptin benzoate",
    "限制項目": "02輸　入",
    "申請商名稱": "1406701100  台灣武田藥品工業股份有限公司",
    "申請商地址": "台北市中山區南京東路三段217號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0328200  TAKEDA PHARMACEUTICAL COMPANY, LTD. (OSAKA PLANT)",
            "製造廠廠址": "17-85 JUSOHONMACHI 2-CHOME, YODOGAWA-KU OSAKA, JAPAN",
            "製造廠公司地址": "1-1 DOCHOMACHI 4-CHOME, CHUO-KU, OSAKA , JAPAN",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6133061413  歐帕生技醫藥股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉光復路1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820400910",
            "成分名稱": "PIOGLITAZONE HYDROCHLORIDE",
            "含量描述": "(as Pioglitazone.………..…15 MG)",
            "含量": "16.5300000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "6820602100",
            "成分名稱": "Alogliptin benzoate",
            "含量描述": "(as Alogliptin…………….…25 MG)",
            "含量": "34.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "blister Photo-105-12-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026953&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI_Oseni -C-USPI 201612_yenting20171106 (clean)_James Lu_201712_R8-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026953&Seq=003&Type=9"
        },
        {
            "title": "歐欣尼膜衣錠-中文仿單-107-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026953&Seq=002&Type=9"
        },
        {
            "title": "Oseni 25mg+15mg_7T Blister_121218-105-12-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026953&Seq=002&Type=8"
        }
    ]
}